David L Linemeyer

Title: The Innovative Contributions of David L. Linemeyer

Introduction: David L. Linemeyer is a prominent inventor based in Westfield, NJ, known for his innovative work in the field of biochemistry. With a total of ten patents to his name, Linemeyer has made significant contributions to the understanding and application of bradykinin receptors.

Latest Patents: Among his latest patents, Linemeyer has developed methodologies surrounding bradykinin B1 receptor antibodies. He has successfully cloned and characterized DNAs encoding bradykinin B1 receptors from mammalian cells. His work includes the engineering of recombinant receptors that effectively bind des-Arg.kallidin and other B1-specific ligands. The expressed DNA in recombinant host cells leads to the production of active recombinant protein. Furthermore, these host cells facilitate the identification of modulators of receptor activity, a crucial aspect of therapeutic development.

Career Highlights: David L. Linemeyer is associated with Merck & Company, Inc., where he has the opportunity to advance his research in drug development and receptor modulation. His extensive experience and innovative approach have made him a key figure in his field, furthering the understanding of receptor-ligand interactions.

Collaborations: Throughout his career, Linemeyer has collaborated with other notable professionals, including Kenneth A. Thomas, Jr., and John W. Hess. These collaborations have enhanced his research capabilities and contributed to the successful development of his patented technologies.

Conclusion: David L. Linemeyer stands out as a significant inventor in the field of receptor research. With ten patents reflecting his innovative ideas and partnerships, his work continues to impact the medical and pharmaceutical industries. His contributions signify a commitment to advancing scientific discovery and developing effective therapies.